Table 8.
Study design | Qual score | Intensity or duration (I or D) | Positive association found? | Positive exposure–response? | Clinical diagnosis | Results in Tables | |
---|---|---|---|---|---|---|---|
Bovenzi (2015) | PC | 72 | D | Yes | Yes* | No | Table 4 |
Dalbøge (2018a) | PC | 63 | D | Yes | Yes | Yes | Table 5 |
Dalbøge (2017) | CC | 76 | D | Yes | Yes | Yes | Table 5 |
Dalbøge (2014) | PC | 58 | D | Yes | Yes | Yes | Table 5 |
Descatha (2012) | PC | 46 | D | No | No | No | Table 4 |
Engholm (2005) | CS | 47 | D | Yes | Yes | No | Table 4 |
Hanvold (2015) | PC | 67 | I | Yes | Yes | No | Table 7 |
Harkness (2003) | PC | 65 | D | Yes | Yes* | No | Table 4 |
Koch (2017) | PC | 56 | I | No | No | No | Table 7 |
Melchior (2006) | CS | 53 | D | Yes | Yes | Yes | Table 4 |
Miranda (2005) | CS | 78 | D | Yes | Yes | Yes | Table 4 |
Miranda (2001) | CS | 44 | D | Yes | Yes** | No | Table 4 |
Punnett (2000) | CC | 73 | I/D | Yes | Yes | Yes | Table 6 |
Seidler (2011) | CC | 57 | D | Yes | Yes | Yes | Table 4 |
Smith (2009) | PC | 67 | D | Yes | No | No | Table 6 |
Svendsen (2013) | PC | 53 | D | Yes | Yes | Yes | Table 5 |
Svendsen (2004a) | CS | 75 | D | Yes | Yes | Yes | Table 7 |
Svendsen (2004b) | CS | 67 | D | Yes | Yes | Yes | Table 7 |
Study design: PC prospective cohort, CC case–control, CS cross-sectional
*Yes = increased risk only shown for the highest level of exposure
**Yes = only significant in univariate analysis